Biotech entity
pharma is the sole category represented across all 1 tracked stories. Fisher Asset Management LLC is most often covered alongside Eli Lilly and Company, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Fisher Asset Management LLC, all published on March 3, 2026.
Last mentioned: Jun 28, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Fisher Asset Management LLC is most often covered alongside Eli Lilly and Company, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Fisher Asset Management LLC, all published on March 3, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Fisher Asset Management LLC. Shared-story counts are live from our verified record — not editorial picks.
Fisher Asset Management LLC expanded its position in Eli Lilly and Company by 3.5% during the third quarter, acquiring an additional 150,595 shares. This move brings the firm's total holdings to approximately 4.45 million shares, signaling continued institutional confidence in the pharmaceutical giant's growth trajectory.
Fisher Asset Management LLC is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
